Sirios Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-45,276
Closed -$1.62M 55
2022
Q3
$1.62M Sell
45,276
-35,254
-44% -$1.46M 0.3% 46
2022
Q2
$3.31M Sell
80,530
-29,570
-27% -$1.44M 0.6% 40
2022
Q1
$6.38M Buy
110,100
+6,907
+7% +$378K 0.85% 34
2021
Q4
$6.06M Sell
103,193
-8,298
-7% -$504K 0.69% 36
2021
Q3
$6.77M Buy
111,491
+6,726
+6% +$394K 0.71% 39
2021
Q2
$6.29M Buy
104,765
+63,242
+152% +$3.17M 0.55% 50
2021
Q1
$1.96M Buy
+41,523
New +$1.71M 0.17% 69

Other funds holding ATEX

Sirios Capital Management's ATEX Position: Q4 2022 in Review

Sirios Capital Management sold out of Anterix (ATEX) in Q4 2022, closing a stake of 45,276 shares — an estimated $1.62M sold.

Sirios Capital Management first reported a position in ATEX in Q1 2021 and held it in 7 quarters. The position peaked at $6.77M in Q3 2021. 92 funds tracked by Wall St. Rank hold ATEX as of Q4 2022.

  • Sirios Capital Management reported no remaining Anterix position as of Q4 2022 after selling out during the quarter.
  • Sirios Capital Management sold 45,276 Anterix shares in Q4 2022, an estimated $1.62M.
  • Sirios Capital Management first reported a position in Anterix in Q1 2021 and held it in 7 quarters.
  • Sirios Capital Management's Anterix position peaked at $6.77M in Q3 2021.
  • 92 funds tracked by Wall St. Rank held Anterix as of Q4 2022.

Based on Sirios Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.